Jones Aranthan II
SEC CIK 1785894 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | Chief Corp. Affairs Off | 91.0K | — | $420.2K | 3 | 2021-07-26 | 2021-09-15 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
Jones Aranthan II made no open-market trades at VNDA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-17 | 2021-09-15 | VNDA | Vanda Pharmaceuticals Inc. | Jones Aranthan II | Chief Corp. Affairs Off | M - OptEx | $11.66 | +12.1K | 91.0K | +15% | +$141.3K |
| D | 2021-09-17 | 2021-09-15 | VNDA | Vanda Pharmaceuticals Inc. | Jones Aranthan II | Chief Corp. Affairs Off | S - Sale+OE | $16.49 | -16.8K | 82.0K | -17% | -$277.4K |
| 2021-07-27 | 2021-07-26 | VNDA | Vanda Pharmaceuticals Inc. | Jones Aranthan II | Chief Corp. Affairs Off | S - Sale | $19.69 | -7,250 | 86.7K | -8% | -$142.8K |
Purchase Sale Sale after option exercise All abbreviations